Cas no 151012-31-6 (2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole)
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole Chemical and Physical Properties
Names and Identifiers
-
- (1-(4-bromobenzyl)-2-butyl-5-chloro-2,3-dihydro-1H-imidazol-4-yl)methanol
- 2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole
- [3-[(4-bromophenyl)methyl]-2-butyl-4-chloro-1,2-dihydroimidazol-5-yl]methanol
- 3-(4-BROMOBENZYL)-2-BUTYL-4-CHLORO-1H-IMIDAZOL-5-YLMETHANOL
- [3-(4-bromo-benzyl)-2-butyl-5-chloro-3H-imidazol-4-yl]-methanol
- 12(S)-HETE
- 12(S)-HYDROXY-(5Z,8Z,10E,14Z)-EICOSATETRAENOIC ACID
- 1H-Imidazole-5-methanol,1-[(4-bromophenyl)methyl]-2-butyl-4-chloro
- 2-n-butyl-1-p-bromobenzyl-4-chloro-1H-imidazole-5-yl-methanol
- 2-n-Butyl-4-chloro-1-(4-bromobenzyl)-1H-imidazole-5-methanol
- 2-n-butyl-4-chloro-5-hydroxymethyl-1-p-bromobenzyl-1H-imidazole
- 3-(4-BROMOBENZYL)-2-BUTYL-5- CHLORO-3H-IMIDAZOL-4-Y]
- [1-(4-Bromobenzyl)-2-butyl-4-chloroimidazol-5-yl]methanol
- 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-methanol
- 3-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-methanol
- (1-(4-bromobenzyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol
- 1H-Imidazole-5-methanol,1-[(4-bromophenyl)methyl]-2-butyl-4-chloro-
- 1-[(4-Bromophenyl)-methyl]-2-butyl-4-chloro-1H-imidazole-5-methanol
- D95646
- FT-0654019
- SCHEMBL984922
- EC 604-770-4
- Q27295005
- AKOS015835613
- UNII-Z544Y1FLS3
- 1H-Imidazole-5-methanol, 1-[(4-bromophenyl)methyl]-2-butyl-4-chloro
- 1H-IMIDAZOLE-5-METHANOL, 1-((4-BROMOPHENYL)METHYL)-2-BUTYL-4-CHLORO-
- NS00077346
- SS-3086
- Z544Y1FLS3
- AC-8196
- 1H-Imidazole-5-methanol, 1-[(4-bromophenyl)methyl]-2-butyl-4-chloro-
- LOSZLEJFCKVKOK-UHFFFAOYSA-N
- [3-[(4-bromophenyl)methyl]-2-butyl-5-chloroimidazol-4-yl]methanol
- [1-(4-bromobenzyl)-2-butyl-4-chloro-1H-imidazol-5-yl]methanol
- 151012-31-6
- 2-n-butyl-1-p-bromobenzyl-4-chloro-1H-imidazole-5-ylmethanol
- (1-(4- Bromobenzyl) -2-butyl-4-chloro-1H-imidazol-5-yl)methanol
-
- MDL: MFCD16879003
- Inchi: 1S/C15H18BrClN2O/c1-2-3-4-14-18-15(17)13(10-20)19(14)9-11-5-7-12(16)8-6-11/h5-8,20H,2-4,9-10H2,1H3
- InChI Key: LOSZLEJFCKVKOK-UHFFFAOYSA-N
- SMILES: BrC1C=CC(=CC=1)CN1C(CO)=C(N=C1CCCC)Cl
Computed Properties
- Exact Mass: 356.02900
- Monoisotopic Mass: 356.02910g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 20
- Rotatable Bond Count: 6
- Complexity: 287
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.1
- Topological Polar Surface Area: 38?2
Experimental Properties
- Color/Form: No data avaiable
- Density: 1.42
- Melting Point: No data available
- Boiling Point: 491.953°C at 760 mmHg
- Flash Point: 251.3±27.3 °C
- Refractive Index: 1.605
- Solubility: 可溶于氯仿(少許)、乙酸乙酯(少許)、甲醇(少許)
- PSA: 38.05000
- LogP: 4.18220
- Vapor Pressure: No data available
- pka: 13.65±0.10(Predicted)
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole Security Information
- Signal Word:Warning
- Hazard Statement: H317-H319
- Warning Statement: P280-P305+P351+P338
- Safety Instruction: H303+H313+H333
- Storage Condition:Sealed in dry,2-8°C
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole Customs Data
- HS CODE:2933290090
- Customs Data:
China Customs Code:
2933290090Overview:
2933290090. Other compounds with non fused imidazole ring in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM187058-5g |
(1-(4-Bromobenzyl)-2-butyl-5-chloro-2,3-dihydro-1H-imidazol-4-yl)methanol |
151012-31-6 | 95% | 5g |
$384 | 2021-08-05 | |
| TRC | B690465-50mg |
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole |
151012-31-6 | 50mg |
$ 115.00 | 2023-09-08 | ||
| TRC | B690465-100mg |
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole |
151012-31-6 | 100mg |
$ 173.00 | 2023-04-18 | ||
| TRC | B690465-250mg |
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole |
151012-31-6 | 250mg |
$ 397.00 | 2023-09-08 | ||
| TRC | B690465-500mg |
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole |
151012-31-6 | 500mg |
$ 730.00 | 2023-09-08 | ||
| TRC | B690465-1g |
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole |
151012-31-6 | 1g |
$ 1355.00 | 2023-04-18 | ||
| Alichem | A069004943-5g |
(1-(4-bromobenzyl)-2-butyl-5-chloro-2,3-dihydro-1H-imidazol-4-yl)methanol |
151012-31-6 | 95% | 5g |
$368.52 | 2022-04-02 | |
| Chemenu | CM187058-5g |
(1-(4-Bromobenzyl)-2-butyl-5-chloro-2,3-dihydro-1H-imidazol-4-yl)methanol |
151012-31-6 | 95% | 5g |
$116 | 2023-03-06 | |
| Chemenu | CM187058-25g |
(1-(4-Bromobenzyl)-2-butyl-5-chloro-2,3-dihydro-1H-imidazol-4-yl)methanol |
151012-31-6 | 95% | 25g |
$305 | 2023-03-06 | |
| Chemenu | CM187058-100g |
(1-(4-Bromobenzyl)-2-butyl-5-chloro-2,3-dihydro-1H-imidazol-4-yl)methanol |
151012-31-6 | 95% | 100g |
$886 | 2023-03-06 |
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole Suppliers
2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole Related Literature
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
-
Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
Additional information on 2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole
Comprehensive Overview of 2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole (CAS No. 151012-31-6)
The compound 2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole (CAS No. 151012-31-6) is a specialized imidazole derivative with a unique structural framework. Its molecular formula, C15H18BrClN2O, highlights the presence of a bromobenzyl group, a chloro substituent, and a hydroxymethyl functionality, making it a versatile intermediate in organic synthesis. Researchers and pharmaceutical developers are increasingly interested in this compound due to its potential applications in medicinal chemistry and drug discovery.
In recent years, the demand for imidazole-based compounds has surged, driven by their role in designing bioactive molecules. The 2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole stands out for its ability to serve as a precursor for heterocyclic scaffolds, which are critical in developing kinase inhibitors and anti-inflammatory agents. Its CAS No. 151012-31-6 is frequently searched in academic databases, reflecting its relevance in high-throughput screening and structure-activity relationship (SAR) studies.
One of the trending topics in chemical research is the exploration of sustainable synthesis methods. The compound’s hydroxymethyl group offers opportunities for green chemistry applications, such as catalytic modifications or biocatalytic transformations. This aligns with the growing emphasis on environmentally friendly processes in the pharmaceutical industry. Additionally, its bromobenzyl moiety is a key feature for cross-coupling reactions, a hot topic in organometallic chemistry.
From a structural perspective, the compound’s imidazole core is notable for its hydrogen-bonding capacity, which enhances its interactions with biological targets. This property is particularly valuable in computational chemistry and molecular docking studies, where researchers aim to predict binding affinities for drug-like molecules. The 4-chloro substituent further contributes to its lipophilicity, a factor often optimized in lead compound development.
Another area of interest is the compound’s potential role in central nervous system (CNS) drug design. The butyl chain and aromatic bromine group may influence blood-brain barrier permeability, a critical parameter for neurotherapeutic agents. This aligns with current searches for novel CNS targets and small-molecule modulators in neurodegenerative research.
In summary, 2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole (CAS No. 151012-31-6) is a multifaceted compound with significant potential in drug development and material science. Its structural features and reactivity profile make it a valuable subject for ongoing research, particularly in the context of precision medicine and targeted therapies. As the scientific community continues to explore its applications, this compound is poised to remain a focal point in innovative chemical synthesis.
151012-31-6 (2-Butyl-1-(4-bromobenzyl)-4-chloro-5-(hydroxymethyl)-1H-imidazole) Related Products
- 1545962-84-2([3-[(4-bromophenyl)methyl]-2-butyl-4-chloro-1,2-dihydroimidazol-5-yl]methanol)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)